Skip to main content
. Author manuscript; available in PMC: 2020 May 6.
Published in final edited form as: Mol Pharm. 2019 Mar 28;16(5):1881–1889. doi: 10.1021/acs.molpharmaceut.8b01246

Figure 1.

Figure 1

(A) Chemical structures of curcumin and (B) its metabolite curcumin-O-glucuronide (COG). (C) Plasma concentration (Cp) of curcumin/curcumin-O-glucuronide mediated pharmacodynamic response of antioxidant and epigenetic gene expression.